NO880731L - Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater. - Google Patents

Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.

Info

Publication number
NO880731L
NO880731L NO880731A NO880731A NO880731L NO 880731 L NO880731 L NO 880731L NO 880731 A NO880731 A NO 880731A NO 880731 A NO880731 A NO 880731A NO 880731 L NO880731 L NO 880731L
Authority
NO
Norway
Prior art keywords
preparation
naphthalene derivatives
pharmasoeytic
procedure
alkyl
Prior art date
Application number
NO880731A
Other languages
English (en)
Norwegian (no)
Other versions
NO880731D0 (no
Inventor
David Thomas Connor
Paul Charles Unangst
Robert James Weikert
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO880731D0 publication Critical patent/NO880731D0/no
Publication of NO880731L publication Critical patent/NO880731L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
NO880731A 1987-02-20 1988-02-19 Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater. NO880731L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/016,811 US4767776A (en) 1987-02-20 1987-02-20 N-1H-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents

Publications (2)

Publication Number Publication Date
NO880731D0 NO880731D0 (no) 1988-02-19
NO880731L true NO880731L (no) 1988-08-22

Family

ID=21779114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880731A NO880731L (no) 1987-02-20 1988-02-19 Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.

Country Status (16)

Country Link
US (1) US4767776A (de)
EP (1) EP0279466B1 (de)
JP (1) JPS63222161A (de)
KR (1) KR880009948A (de)
AT (1) ATE89556T1 (de)
AU (1) AU596054B2 (de)
DE (1) DE3881073T2 (de)
DK (1) DK84088A (de)
ES (1) ES2054715T3 (de)
FI (1) FI880748A7 (de)
IE (1) IE61482B1 (de)
NO (1) NO880731L (de)
NZ (1) NZ223477A (de)
PH (1) PH24687A (de)
PT (1) PT86785B (de)
ZA (1) ZA88385B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5257726A (en) * 1985-08-14 1993-11-02 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for flowable media
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5434188A (en) * 1994-03-07 1995-07-18 Warner-Lambert Company 1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2003104178A1 (en) * 2002-06-07 2003-12-18 Cortical Pty Ltd Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
BRPI0410913A (pt) * 2003-06-05 2006-06-27 Warner Lambert Co benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
CA2527779A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-substituted indoles and derivatives thereof as therapeutic agents
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
MXPA05013210A (es) * 2003-06-05 2006-03-09 Warner Lambert Co Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
WO2004108709A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
JP2006526614A (ja) * 2003-06-05 2006-11-24 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 治療用剤としての３−アリールスルファニル及び３−ヘテロアリールスルファニル置換ベンゾ［ｂ］チオフェン
US7318709B2 (en) * 2003-08-27 2008-01-15 Haldex Brake Corporation Pump valve assembly
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
RS56912B1 (sr) * 2011-12-21 2018-05-31 Syngenta Ltd Herbicidna jedinjenja
BR112014026823A2 (pt) * 2012-04-27 2017-06-27 Basf Se compostos de n-(tetrazol-5-il) e n-(triazol-5-il)arilcarboxamida substituída e seu uso como herbicidas.
WO2014184073A1 (en) * 2013-05-15 2014-11-20 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343827A (en) * 1971-06-15 1974-01-16 Science Union & Cie Acylaminotetrazoles and process for preparing them
BE789822A (fr) * 1971-10-08 1973-04-06 Allen & Hanburys Ltd Nouveaux composes heterocycliques
US4145350A (en) * 1972-09-06 1979-03-20 Burroughs Wellcome Co. Cyclic sulphur compounds triazolyl substituted phenoxathin 10, 10 dioxides
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
US4147694A (en) * 1977-02-07 1979-04-03 Riker Laboratories, Inc. 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
US4474792A (en) * 1979-06-18 1984-10-02 Riker Laboratories, Inc. N-Tetrazolyl benzamides and anti-allergic use thereof

Also Published As

Publication number Publication date
DK84088D0 (da) 1988-02-18
PT86785B (pt) 1992-05-29
NO880731D0 (no) 1988-02-19
ZA88385B (en) 1989-09-27
PH24687A (en) 1990-09-07
FI880748A7 (fi) 1988-08-21
US4767776A (en) 1988-08-30
EP0279466B1 (de) 1993-05-19
DE3881073D1 (de) 1993-06-24
AU596054B2 (en) 1990-04-12
ES2054715T3 (es) 1994-08-16
ATE89556T1 (de) 1993-06-15
DE3881073T2 (de) 1993-09-02
DK84088A (da) 1988-08-21
JPS63222161A (ja) 1988-09-16
FI880748A0 (fi) 1988-02-17
EP0279466A2 (de) 1988-08-24
IE880125L (en) 1988-08-20
IE61482B1 (en) 1994-11-02
KR880009948A (ko) 1988-10-06
EP0279466A3 (en) 1989-08-02
NZ223477A (en) 1990-01-29
AU1111988A (en) 1988-09-01
PT86785A (pt) 1988-03-01

Similar Documents

Publication Publication Date Title
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
GEP20043315B (en) Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
NO880731D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
NO833900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalenderivater
AU624896B2 (en) Anti-inflammatory aryl derivatives
AU3636089A (en) Hydrazine derivatives for pharmaceutical use
LT99036A (en) Local anesthetic for external use
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
DE3464603D1 (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acid derivatives, processes for the preparation thereof, and antiallergic agent containing the same
ATE63908T1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
ATE36316T1 (de) Gegen psoriasis wirkende naphthalin-verbindungen.
AU7668087A (en) Immunologically active phenyl and substituted carbonyl amino heterocyclic derivatives
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE69000806D1 (de) Indol-derivate.
AU2013888A (en) Uricosuric composition
GB1203430A (en) Heterocyclic spiro compounds
IE792287L (en) Urethane derivatives
ATE77362T1 (de) Naphthalenische antipsoriasismittel und ihr herstellungsverfahren.
NO166529C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3569733D1 (en) Use of some 2-û2-û4-phenyl-1-piperazinyl¨ethyl¨-1h-naphth-û1,2-d¨imidazole derivatives and their pharmaceutically acceptable salts for the manufacture of a medicament for the treatment of cardiovascular diseases
ITMI921151A1 (it) Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione
MY102050A (en) Imidazole anologs of mevalonolactone and derivatives thereof